Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972293304> ?p ?o ?g. }
- W1972293304 endingPage "1111" @default.
- W1972293304 startingPage "1105" @default.
- W1972293304 abstract "Although the safety of drug-eluting stents has been under considerable scrutiny, limited real-world follow-up data extending up to 4 years are available. The randomized clinical trials carefully selected patients and are not reflective of everyday practice. From April to October 2002, 508 consecutive patients treated with sirolimus-eluting stents (SES) were enrolled. The control group consisted of 450 patients treated with bare-metal stents during the preceding 6 months. After 4 years of follow-up, the incidence of composite major adverse clinical events (all-cause death, myocardial infarction, or target vessel revascularization) was found to be significantly lower in the SES group (23.0% vs 28.7%, adjusted hazard ratio 0.66, 95% confidence interval 0.51 to 0.86), as were rates of target vessel revascularization (12.2% vs 17.8%, adjusted hazard ratio 0.57, 95% confidence interval 0.39 to 0.83). There were no differences in all-cause mortality (10.5% for SES vs 10.6% for bare-metal stents, p = 0.9) or in the rates of cardiac death (4.5% vs 6.9%, p = 0.1). Although there was no difference in overall stent thrombosis (2.3% vs 2.2%, p = 1.0), SES had a higher rate of very late stent thrombosis (1.4% vs 0%, p = 0.02), balanced by a lower rate of early stent thrombosis (0.4% vs 1.8%, p = 0.05). In conclusion, after 4 years, SES were found to remain safe and effective compared with bare-metal stents. Nevertheless, the higher rate of very late stent thrombosis remains a concern. Longer term follow-up will be required to determine the extent of this problem. Although the safety of drug-eluting stents has been under considerable scrutiny, limited real-world follow-up data extending up to 4 years are available. The randomized clinical trials carefully selected patients and are not reflective of everyday practice. From April to October 2002, 508 consecutive patients treated with sirolimus-eluting stents (SES) were enrolled. The control group consisted of 450 patients treated with bare-metal stents during the preceding 6 months. After 4 years of follow-up, the incidence of composite major adverse clinical events (all-cause death, myocardial infarction, or target vessel revascularization) was found to be significantly lower in the SES group (23.0% vs 28.7%, adjusted hazard ratio 0.66, 95% confidence interval 0.51 to 0.86), as were rates of target vessel revascularization (12.2% vs 17.8%, adjusted hazard ratio 0.57, 95% confidence interval 0.39 to 0.83). There were no differences in all-cause mortality (10.5% for SES vs 10.6% for bare-metal stents, p = 0.9) or in the rates of cardiac death (4.5% vs 6.9%, p = 0.1). Although there was no difference in overall stent thrombosis (2.3% vs 2.2%, p = 1.0), SES had a higher rate of very late stent thrombosis (1.4% vs 0%, p = 0.02), balanced by a lower rate of early stent thrombosis (0.4% vs 1.8%, p = 0.05). In conclusion, after 4 years, SES were found to remain safe and effective compared with bare-metal stents. Nevertheless, the higher rate of very late stent thrombosis remains a concern. Longer term follow-up will be required to determine the extent of this problem." @default.
- W1972293304 created "2016-06-24" @default.
- W1972293304 creator A5000807712 @default.
- W1972293304 creator A5010222445 @default.
- W1972293304 creator A5011940077 @default.
- W1972293304 creator A5026031312 @default.
- W1972293304 creator A5033963527 @default.
- W1972293304 creator A5063792624 @default.
- W1972293304 creator A5066083709 @default.
- W1972293304 date "2008-04-01" @default.
- W1972293304 modified "2023-09-23" @default.
- W1972293304 title "Four-Year Clinical Follow-Up of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital Registry" @default.
- W1972293304 cites W134324083 @default.
- W1972293304 cites W1527614413 @default.
- W1972293304 cites W165507686 @default.
- W1972293304 cites W1971428935 @default.
- W1972293304 cites W1998792752 @default.
- W1972293304 cites W2010164032 @default.
- W1972293304 cites W2036304712 @default.
- W1972293304 cites W2049120615 @default.
- W1972293304 cites W2055767022 @default.
- W1972293304 cites W2087150869 @default.
- W1972293304 cites W2092998815 @default.
- W1972293304 cites W2100113253 @default.
- W1972293304 cites W2106820552 @default.
- W1972293304 cites W2113063128 @default.
- W1972293304 cites W2135866603 @default.
- W1972293304 cites W2141165366 @default.
- W1972293304 cites W2146743728 @default.
- W1972293304 cites W2164466909 @default.
- W1972293304 cites W2330950446 @default.
- W1972293304 cites W2616180029 @default.
- W1972293304 cites W4244648663 @default.
- W1972293304 doi "https://doi.org/10.1016/j.amjcard.2007.11.074" @default.
- W1972293304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18394442" @default.
- W1972293304 hasPublicationYear "2008" @default.
- W1972293304 type Work @default.
- W1972293304 sameAs 1972293304 @default.
- W1972293304 citedByCount "37" @default.
- W1972293304 countsByYear W19722933042012 @default.
- W1972293304 countsByYear W19722933042013 @default.
- W1972293304 countsByYear W19722933042014 @default.
- W1972293304 countsByYear W19722933042016 @default.
- W1972293304 countsByYear W19722933042017 @default.
- W1972293304 countsByYear W19722933042018 @default.
- W1972293304 crossrefType "journal-article" @default.
- W1972293304 hasAuthorship W1972293304A5000807712 @default.
- W1972293304 hasAuthorship W1972293304A5010222445 @default.
- W1972293304 hasAuthorship W1972293304A5011940077 @default.
- W1972293304 hasAuthorship W1972293304A5026031312 @default.
- W1972293304 hasAuthorship W1972293304A5033963527 @default.
- W1972293304 hasAuthorship W1972293304A5063792624 @default.
- W1972293304 hasAuthorship W1972293304A5066083709 @default.
- W1972293304 hasConcept C120665830 @default.
- W1972293304 hasConcept C121332964 @default.
- W1972293304 hasConcept C126322002 @default.
- W1972293304 hasConcept C141071460 @default.
- W1972293304 hasConcept C164705383 @default.
- W1972293304 hasConcept C207103383 @default.
- W1972293304 hasConcept C2777546689 @default.
- W1972293304 hasConcept C2778283817 @default.
- W1972293304 hasConcept C2778583881 @default.
- W1972293304 hasConcept C2779464278 @default.
- W1972293304 hasConcept C2779983491 @default.
- W1972293304 hasConcept C2780868729 @default.
- W1972293304 hasConcept C3019562390 @default.
- W1972293304 hasConcept C44249647 @default.
- W1972293304 hasConcept C500558357 @default.
- W1972293304 hasConcept C61511704 @default.
- W1972293304 hasConcept C71924100 @default.
- W1972293304 hasConceptScore W1972293304C120665830 @default.
- W1972293304 hasConceptScore W1972293304C121332964 @default.
- W1972293304 hasConceptScore W1972293304C126322002 @default.
- W1972293304 hasConceptScore W1972293304C141071460 @default.
- W1972293304 hasConceptScore W1972293304C164705383 @default.
- W1972293304 hasConceptScore W1972293304C207103383 @default.
- W1972293304 hasConceptScore W1972293304C2777546689 @default.
- W1972293304 hasConceptScore W1972293304C2778283817 @default.
- W1972293304 hasConceptScore W1972293304C2778583881 @default.
- W1972293304 hasConceptScore W1972293304C2779464278 @default.
- W1972293304 hasConceptScore W1972293304C2779983491 @default.
- W1972293304 hasConceptScore W1972293304C2780868729 @default.
- W1972293304 hasConceptScore W1972293304C3019562390 @default.
- W1972293304 hasConceptScore W1972293304C44249647 @default.
- W1972293304 hasConceptScore W1972293304C500558357 @default.
- W1972293304 hasConceptScore W1972293304C61511704 @default.
- W1972293304 hasConceptScore W1972293304C71924100 @default.
- W1972293304 hasIssue "8" @default.
- W1972293304 hasLocation W19722933041 @default.
- W1972293304 hasLocation W19722933042 @default.
- W1972293304 hasOpenAccess W1972293304 @default.
- W1972293304 hasPrimaryLocation W19722933041 @default.
- W1972293304 hasRelatedWork W1972702180 @default.
- W1972293304 hasRelatedWork W2015473457 @default.
- W1972293304 hasRelatedWork W2034130369 @default.
- W1972293304 hasRelatedWork W2091123380 @default.
- W1972293304 hasRelatedWork W2092998815 @default.
- W1972293304 hasRelatedWork W2322145210 @default.